G64D (p.Gly64Asp) variant of TNFRSF13C (Q96RJ3)

G64D (p.Gly64Asp) in TNFRSF13C (Q96RJ3) is a missense change. Clinical records from EBI and UniProt describe it as benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.23 / 1. The record also includes population frequency data.

G64D (p.Gly64Asp) variant details